GDF15: from biomarker to target in cancer cachexia
Trends in Cancer · 2025-11 · 11 (11) · 1093-1105
DOI: 10.1016/j.trecan.2025.06.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025-11. Verfasst von Max Hüllwegen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry, University Medical Center Göttingen (UMG), Göttingen, Germany. Hauptthemen laut MEDLINE: Neoplasms, Growth Differentiation Factor 15, Cachexia, Biomarkers, Tumor. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Most patients with advanced cancer suffer from cachexia, a complex metabolic disorder characterized by unintentional body weight loss that diminishes their quality of life and reduces the effectiveness of therapies. Currently, effective treatments for cachexia remain elusive. Growth differentiation factor 15 (GDF15) is a nonspecific blood biomarker of cancer, hyperemesis gravidarum, and various chronic diseases. GDF15 acts through GDNF family receptor α-like (GFRAL) receptors in the hindbrain to influence food intake, nausea, body weight, and insulin sensitivity. In this review we synthesize the current literature on the role of GDF15 in regulating metabolism and immunosuppression, and elucidate how these processes impact on cancer progression. We highlight recent clinical trials demonstrating that targeting GDF15 can overcome resistance to immunotherapy and increase physical activity, appetite, and weight gain in cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Chemistry, University Medical Center Göttingen (UMG), Göttingen, Germany.
- Department of Molecular Physiology of Exercise and Nutrition, German Institute of Human Nutrition (DIfE), Potsdam-Rehbruecke, Nuthetal, Germany; German Center for Diabetes Research (DZD), 85764 Munich-Neuherberg, German…
- Department of Cardiology and Pneumology, University of Göttingen Medical Center (UMG), Göttingen, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Lower Saxony, Göttingen, Germany.
- Department of Clinical Chemistry, University Medical Center Göttingen (UMG), Göttingen, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Lower Saxony, Göttingen, Germany. Electronic address: andre…
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Hüllwegen, M., Kleinert, M., von Haehling, S., & Fischer, A. (2025). GDF15: from biomarker to target in cancer cachexia. Trends in Cancer, 11(11), 1093-1105. https://doi.org/10.1016/j.trecan.2025.06.007
Vancouver
Hüllwegen M, Kleinert M, von Haehling S, Fischer A. GDF15: from biomarker to target in cancer cachexia. Trends in Cancer. 2025;11(11):1093-1105. doi:10.1016/j.trecan.2025.06.007
BibTeX
@article{Hllwegen2025,
author = {Hüllwegen, Max and Kleinert, Maximilian and von Haehling, Stephan and Fischer, Andreas},
title = {GDF15: from biomarker to target in cancer cachexia},
journal = {Trends in Cancer},
year = {2025},
volume = {11},
number = {11},
pages = {1093--1105},
doi = {10.1016/j.trecan.2025.06.007}
}
EUVIMED